Hematologic complications, healthcare utilization, and costs in commercially insured patients with myelodysplastic syndrome receiving supportive care.

Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population.

Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.

Health Care Utilization and Costs of Publicly-Insured Children with Diabetes in California.

Healthcare utilization and costs associated with gastroparesis.

Resource utilization and cost in a commercially insured population with schizophrenia.

Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor.

Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®).

Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with H.P. Acthar Gel(®).

DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women.

Healthcare utilization and costs in patients with benign prostatic hyperplasia: a population-based study.

Cardiovascular-related healthcare resource utilization and costs in patients with hypertension switching from metoprolol to nebivolol.

Retrospective study comparing healthcare costs and utilization between commercially insured patients with type 2 diabetes mellitus who are newly initiating exenatide once weekly or liraglutide in the United States.

Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.

Together Achieving More: Primary Care Team Communication and Alcohol-Related Healthcare Utilization and Costs.

Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.

Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia.

Health Care Utilization and Costs in Patients with Hepatitis B related Disease in Jiangsu, China.

Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancer†.

Food-induced anaphylaxis among commercially insured US adults: patient concordance with postdischarge care guidelines.

Incremental healthcare resource utilization and costs in US patients with Cushing's disease compared with diabetes mellitus and population controls.

Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome.

Cost-effectiveness of bronchial thermoplasty in commercially-insured patients with poorly controlled, severe, persistent asthma.

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.

Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopram.

Suggest Documents

Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population.

Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.

Health Care Utilization and Costs of Publicly-Insured Children with Diabetes in California.

Healthcare utilization and costs associated with gastroparesis.

Resource utilization and cost in a commercially insured population with schizophrenia.

Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor.

Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®).

Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with H.P. Acthar Gel(®).

DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women.

Healthcare utilization and costs in patients with benign prostatic hyperplasia: a population-based study.

Cardiovascular-related healthcare resource utilization and costs in patients with hypertension switching from metoprolol to nebivolol.

Retrospective study comparing healthcare costs and utilization between commercially insured patients with type 2 diabetes mellitus who are newly initiating exenatide once weekly or liraglutide in the United States.

Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.

Together Achieving More: Primary Care Team Communication and Alcohol-Related Healthcare Utilization and Costs.

Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.

Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia.

Health Care Utilization and Costs in Patients with Hepatitis B related Disease in Jiangsu, China.

Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancer†.

Food-induced anaphylaxis among commercially insured US adults: patient concordance with postdischarge care guidelines.

Incremental healthcare resource utilization and costs in US patients with Cushing's disease compared with diabetes mellitus and population controls.

Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome.

Cost-effectiveness of bronchial thermoplasty in commercially-insured patients with poorly controlled, severe, persistent asthma.

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.

Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopram.

Hematologic complications, healthcare utilization, and costs in commercially insured patients with myelodysplastic syndrome receiving supportive care.

Recommend Documents

Follow Us